Table 1.

Summary of Participant Clinical Characteristics

					CD4 T cells (cells/mm3)
	Age, years (ART start)	Sex	Days between EDI and ART start	VL pre-ART (cells/ml)	Pre-ART	2 Years ART	5 Years ART
Early ART	37	Male	75	7,988	538	673	623
	45	Male	156	289,235	369	571	—
	54	Male	49	103,595	846	987	1,404
	34	Male	176	1,244,229	551	695	847
	40	Male	44	11,066	595	915	—
	27	Male	85	35,326	—	1,029	—
	34	Male	65	133,400	445	—	832
	47	Male	49	75,068	509	692	744
	25	Male	67	62,761	549	883	908
	53	Male	28	2,527,663	521	714	893
	52	Male	21	750,000	—	910	—
	54	Male	49	500,000	—	1,209	856
	45	Male	23	500,000	190	—	704
	50	Male	182	148,840	583	—	619
	22	Male	60	55,557	875	—	701
	41	Male	84	114,843	—	951	786
	48	Male	124	128,006	449	498	—
	40	Male	29	237,725	730	1,365	—
	44	Male	28	586,073	136	394	—
Median	44	—	60	133,400	538	883	809
Delayed ART	43	Male	5,177	10,732	377	607	—
	53	Female	2,181	28,896	214	570	421
	50	Male	814	49,330	295	460	755
	42	Male	—	92,400	249	338	—
	41	Male	—	9,211	336	407	—
	39	Male	1,692	4,774	441	529	665
	32	Male	615	66,018	610	896	—
	47	Male	631	82,713	—	526	—
	47	Male	—	54,100	886	1,020	—
	39	Male	2,124	22,907	462	444	498
	27	Male	942	271,630	—	583	452
	40	Male	—	132,724	—	526	—
	27	Male	—	71,281	348	619	—
	35	Male	—	150,167	—	—	535
	56	Male	945	356,000	—	411	517
	37	Male	897	64,616	435	502	740
	52	Male	—	34,031	381	702	—
	52	Male	1,207	286,420	265	862	778
	43	Male	928	29,762	331	650	—
	52	Male	554	21,233	528	659	804
	62	Male	729	64,411	304	524	—
	52	Male	1,459	162,600	—	398	—
	39	Male	674	66,552	471	445	855
Median	43	—	935	64,616	377	528	665

Clinical characteristics of individual study participants (and median values) in the Early and Delayed ART groups.

ART, antiretroviral therapy; EDI, estimated date of infection; VL, viral load.